Plasma CAMK2A predicts chemotherapy resistance in metastatic triple negative breast cancer

Background: Chemotherapy resistance is a great obstacle in effective treatment for metastatic triple negative breast cancer (TNBC). The ability to predict chemotherapy response would allow chemotherapy administration to be directed toward only those patients who would benefit, thus maximizing treatm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Clin Exp Pathol
Egile Nagusiak: Shao, Bin, Tian, Zhihua, Ding, Huirong, Wang, Qingsong, Song, Guohong, Di, Lijun, Zhang, Hong, Li, Huiping, Shen, Jing
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: e-Century Publishing Corporation 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6958019/
https://ncbi.nlm.nih.gov/pubmed/31938151
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak